|
DPY30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.367600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.189400E-01 |
| Normal-vs-Stage2 |
3.659400E-01 |
| Normal-vs-Stage3 |
8.625200E-01 |
| Normal-vs-Stage4 |
2.924400E-01 |
| Stage1-vs-Stage2 |
2.580800E-01 |
| Stage1-vs-Stage3 |
9.743200E-01 |
| Stage1-vs-Stage4 |
1.562610E-01 |
| Stage2-vs-Stage3 |
3.762400E-01 |
| Stage2-vs-Stage4 |
9.329200E-01 |
| Stage3-vs-Stage4 |
3.428200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.042400E-01 |
| Normal-vs-AfricanAmerican |
8.882800E-01 |
| Normal-vs-Asian |
5.006000E-01 |
| Caucasian-vs-AfricanAmerican |
7.391200E-01 |
| Caucasian-vs-Asian |
8.458800E-01 |
| AfricanAmerican-vs-Asian |
6.861200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.306400E-01 |
| Normal-vs-Female |
7.451600E-01 |
| Male-vs-Female |
3.905200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.744800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.569600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.594200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.410400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.169000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.160200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.541600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.444200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.253200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.553400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.705800E-01 |
| Classical-VS-Follicular |
6.307600E-02 |
| Classical-VS-Other |
2.943800E-01 |
| Classical-VS-Normal |
4.160200E-01 |
| Tall-VS-Follicular |
7.061500E-02 |
| Tall-VS-Other |
1.730160E-01 |
| Tall-VS-Normal |
3.920400E-01 |
| Follicular-VS-Other |
8.671600E-01 |
| Follicular-VS-Normal |
1.780610E-01 |
| Other-VS-Normal |
3.244000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.744800E-01 |
| Normal-vs-N1 |
8.535200E-01 |
| N0-vs-N1 |
8.143800E-01 |
|
|
